LONGITUDINAL STUDY ON LIVER FUNCTIONS IN PATIENTS WITH THALASSEMIA MAJOR BEFORE AND AFTER DEFERASIROX (DFX) THERAPY
With regular blood transfusion and iron chelation therapy, most patients with thalassemia major (BTM) now survive beyond the third decade of life . Liver disease is becoming an important cause of morbidity and mortality in these patients. Chronic hepatitis and/or severe iron overload are important c...
Saved in:
Main Authors: | Ashraf Tawfik Soliman, Mohamed Yassin, Fawzia AlYafei, Lolwa Al-Naimi, Noora Almarri, Aml Sabt, Vincenzo De Sanctis |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2014-04-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/1385 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
by: Ali Taher
Published: (2018-11-01) -
LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOSING
by: Jassada Buaboonnam, et al.
Published: (2021-10-01) -
Assessing the auditory effects of oral chelation therapy drug Deferasirox in individuals with β‐thalassemia major
by: Balwinder S. Tiwana, et al.
Published: (2024-12-01) -
Comparative study of efficacy of different iron chelating agents in treatment of iron overload in children with Beta Thalassemia Major
by: adel abd elhaleim hagag
Published: (2014-08-01) -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
by: adel abd elhaleim hagag
Published: (2013-11-01)